Skip to content

Cost-effectiveness of IUI, IVF and ICSI for male subfertility. The MAle Subfertility Therapy Effectiveness Rcts (MASTER).

Cost-effectiveness of IUI, IVF and ICSI for male subfertility. The MAle Subfertility Therapy Effectiveness Rcts (MASTER). - MASTER study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39669
Enrollment
830
Registered
2013-04-03
Start date
2013-05-13
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

decreased male fertility Male subfertility

Interventions

RCT 1: 3 cycles of IUI, followed by 3 cycles of IUI-COH. Control: expectant management. Treatment time horizon 6 months. RCT 2: 3 cycles of ICSI, including transfer of cryoembryos. Control: 3 cycles

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: RCT 1: - Male subfertility: Pre-wash TMSC 3.10^6 - Age female partner 18-42 years - Failure to conceive for at least 12 - Couple who start treatment for a first, or first after a successful pregnancy, cycle RCT 2 - Age female partner between: 18-42 years - Male subfertility: Pre-wash TMSC

Exclusion criteria

Exclusion criteria: RCT 1: - Female partner with polycystic ovary syndrome or any other anovulation, severe endometriosis, double-sided tubal pathology, endocrinopathological disease (Cushing syndrome, adrenal hyperplasia, hyperprolactinemia, acromegaly, imminent ovarian failure, premature ovarian failure, hypothalamic amenorrhea and diabetes mellitus (type I) - Major uterine or ovarian abnormalities detected by TVS which is classified as contraindication for pregnancy or medically assisted reproduction RCT 2: - Severe male subfertility: Post-wash TMSC

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy leading to live birth

Secondary

MeasureTime frame
Time to pregnancy, miscarriage, multiple pregnancy, live birth, pregnancy complications, perinatal outcome, (in-)direct costs, quality of life and patient preferences

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)